Resources

The industries we serve are fast moving and complex with changing regulations, technology and innovations. The physIQ team is here to help you make sense of it all. Check back often for updated resources.

Oncology Study with Janssen

Chris Economos of physIQ and Bert Hartog of Janssen discuss how they are working with HagaHospital (The Hague, Netherlands) to deploy accelerateIQTM to detect physiological anomalies during and after anti-cancer treatment. Funded by Janssen Pharmaceuticals, the study is evaluating how clinicians can leverage this technology to proactively identify and manage adverse events that may result from chemotherapy and immunotherapy, with potential to establish safety-related digital biomarkers.

FEATURED RESOURCES

Impact on Care Delivery Model
Impact on Care Delivery Model

Dr. Steve Steinhubl shares how wearable biosensor technology and continuous monitoring impacts the care delivery model. 

Heart Failure Management: Are You Ready for the Next 5 Years?
Heart Failure Management: Are You Ready for the Next 5 Years?

Heart failure is one of the most pressing issues in population health.  With almost 1 million hospitalizations per year, it represents a huge opportunity to improve outcomes and lower costs by leveraging technology.  Heart failure nurse practitioner Karen Larimer explores what's on tap to address the unmet needs for these patients.

Oncology Study with Janssen
Oncology Study with Janssen

PhysIQ partnered with Janssen to deploy accelerateIQTM to detect physiological anomalies during and after anti-cancer treatment. 

Contact us and transform the future of real-world patient insight.

At physIQ, we welcome the opportunity to speak with potential customers, partners or anyone with an interest in learning more about the transformative potential of our technology.

Contact Us